Sera Prognostics Inc-A

Penny Stocks Biotech Stocks Healthcare Stocks

$2.52

+0.20 (+8.62%)

As of Feb 8, 2:12 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +1,244.8% upside

Low Target $29.33

Average Target $33.89

High Target $54.04

Current Price $2.52

Current
$2.52

Target
$33.89

$29.33 $33.89 avg $54.04

Scenario Analysis

Bear Case

$29.33

1,063.9%

Low target

Base Case

$33.89

+1,244.8%

Avg target

Bull Case

$54.04

+2,044.4%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$35.44

-92.9% from high

52-Week Low

$27.88

+-91.0% from low

Target vs 52W High

$33.89

-4.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%